APOE isoforms control pathogenic subretinal inflammation in age-related macular degeneration by Levy, Olivier et al.
Neurobiology of Disease
APOE Isoforms Control Pathogenic Subretinal Inflammation
in Age-Related Macular Degeneration
Olivier Levy,1,2,3 XSophie Lavalette,1,2,3 Shulong J. Hu,1,2,3 Michael Housset,1,2,3 William Raoul,1,2,3 Chiara Eandi,5
X Jose´-Alain Sahel,1,2,3,4 Patrick M. Sullivan,6 XXavier Guillonneau,1,2,3 and XFlorian Sennlaub1,2,3
1Institut National de la Sante´ et de la Recherche Me´dicale, U 968, Paris, F-75012, France, 2Sorbonne Universite´s, Universite´ Pierre et Marie Curie Paris 06,
Unite´ Mixte de Recherche S 968, Institut de la Vision, Paris, F-75012, France, 3CNRS, Unite´ Mixte de Recherche 7210, Paris, F-75012, France, 4Centre
Hospitalier National d’Ophtalmologie des Quinze-Vingts, Institut National de la Sante´ et de la Recherche Me´dicale-DHOS CIC 503, Paris, F-75012, France,
5Department of Surgical Sciences, Eye Clinic, University of Torino, Torino, Italy, and 6Department of Medicine, Centers for Aging and Geriatric Research
Education and Clinical Center, Durham Veteran Affairs Medical Center, Duke University, Durham, North Carolina 27710
Contrary to Alzheimer’s disease (AD), the APOE2 allele increases and the APOE4 allele reduces the risk to develop age-related macular
degeneration (AMD) compared with themost common APOE3 allele. The underlyingmechanism for this association with AMD and the
reason for the puzzling difference with AD are unknown. We previously demonstrated that pathogenic subretinal mononuclear phago-
cytes (MPs) accumulate in Cx3cr1-deficient mice due to the overexpression of APOE, interleukin-6, and CC chemokine ligand 2 (CCL2).
We here show using targeted replacement mice expressing the human APOE isoforms (TRE2, TRE3, and TRE4) that MPs of TRE2mice
express increased levels of APOE, interleukin-6, and CCL2 and develop subretinal MP accumulation, photoreceptor degeneration, and
exaggerated choroidal neovascularization similar toAMD.Pharmacological inhibitionof the cytokine induction inhibited thepathogenic
subretinal inflammation. In the context of APOE-dependent subretinal inflammation in Cx3cr1GFP/GFP mice, the APOE4 allele led to
diminished APOE and CCL2 levels and protected Cx3cr1GFP/GFP mice against harmful subretinal MP accumulation observed in
Cx3cr1GFP/GFPTRE3mice. Our study shows that pathogenic subretinal inflammation is APOE isoform-dependent and provides the ratio-
nale for thepreviouslyunexplained implicationof theAPOE2 isoformasa risk factor and theAPOE4 isoformasaprotective factor inAMD
pathogenesis.
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Introduction
In humans, the APOE gene has three common genetic variants
(APOE2, APOE3, and APOE4), due to two polymorphisms
rs7412 and rs429358 that are imbedded in a well-defined CpG
island, and lead to two cysteine-arginine interchanges at residues
112 and 158 (Yu et al., 2013). The APOE2 allele is associated with
higher APOE concentrations in plasma, CSF, and brain tissue
(Riddell et al., 2008; Bales et al., 2009) due to impaired clearance
caused by APOE2’s decreased affinity for the low-density lipo-
protein receptor (Mahley and Rall, 2000). Its transcription can
Received June 29, 2015; revised Aug. 12, 2015; accepted Aug. 18, 2015.
Author contributions: O.L. and F.S. designed research; O.L., S.L., S.J.H., C.E., M.H., W.R., and F.S. performed
research; O.L., S.L., J.-A.S., P.M.S., X.G., and F.S. analyzed data; O.L., P.M.S., X.G., and F.S. wrote the paper.
This work was supported by Institut National de la Sante´ et de la Recherche Me´dicale, ANR Maladies Neu-
rologiques et Psychiatriques Grant ANR-08-MNPS-003, Grant ANR Geno 2009 R09099DS, Labex Lifesenses, Carnot,
ERC starting Grant ERC-2007 St.G. 210345, and Association de Pre´voyance Sante´ de ALLIANZ.
The authors declare no competing financial interests.
Correspondence should be addressed to Dr. Florian Sennlaub, Institut National de la Sante´ et de la Recherche
Me´dicale, Unite´ Mixte de Recherche S 968, Institut de la Vision, Paris, F-75012, France. E-mail:
florian.sennlaub@inserm.fr.
DOI:10.1523/JNEUROSCI.2468-15.2015
Copyright © 2015 the authors 0270-6474/15/3513568-09$15.00/0
Significance Statement
The understanding of how genetic predisposing factors, which play a major role in age-related macular degeneration (AMD),
participate in its pathogenesis is an important clue to decipher the pathomechanismanddevelop efficient therapies. In this study,
we used transgenic, targeted replacementmice that carry the three human APOE isoform-defining sequences at themouse APOE
chromosomal location and express the human APOE isoforms. Our study is the first to show how APOE2 provokes and APOE4
inhibits the cardinal AMD features, inflammation, degeneration, and exaggerated neovascularization. Our findings reflect the
clinical association of the genetic predisposition that was recently confirmed in amajor pooled analysis. They emphasize the role
of APOE in inflammation and inflammation in AMD.
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also be increased in certain cell types (astrocytes, neurons) due to
the loss of CpG sites associated with APOE3 and APOE4 alleles
(Yu et al., 2013). Compared with the APOE3 allele, the APOE4
allele is transcribed similarly in neurons and astrocytes (Yu et al.,
2013), but its protein concentrations in plasma, CSF, and brain
parenchyma are decreased (Riddell et al., 2008; Bales et al., 2009;
Sullivan et al., 2011). The structural changes in the APOE4 pro-
tein also lead to diminished association with high-density lipo-
protein (Dong and Weisgraber, 1996) and impaired reverse
cholesterol transport (Heeren et al., 2004; Mahley et al., 2009).
APOE2 allele carriers are at increased risk for developing late
age-related macular degeneration (AMD) [odds ratio (OR) 
1.83 for homozygote APOE2 allele carriers] and are protected
against Alzheimer’s disease (AD), whereas the APOE4 allele pro-
tects against AMD (OR 0.72 per haplotype) and is a risk factor
for AD compared with the most common APOE3 allele (Mahley
and Rall, 2000; McKay et al., 2011). This association was recently
confirmed in a pooled study of 20,000 subjects (McKay et al.,
2011). It is found for both clinical forms of late AMD: wet AMD,
which is defined by choroidal neovascularization (CNV) and
geographic atrophy, which is characterized by an extending le-
sion of both the retinal pigment epithelium (RPE) and photore-
ceptors. In AD, the APOE4 allele is associated with greater
-amyloid burden, possibly due to reduced efficacy in clearance
of -amyloid via multiple pathways (Bales et al., 2009; Mahley et
al., 2009). The mechanism underlying the associations of the
APOE isoforms with AMD remains unexplained.
APOE is the main lipoprotein of the brain and the retina
(Mahley and Rall, 2000; Anderson et al., 2001). It is strongly
expressed in mononuclear phagocytes (MPs), such as macro-
phages and microglial cells (Peri and Nu¨sslein-Volhard, 2008;
Levy et al., 2015), and plays a major role in macrophage lipid
efflux and reverse cholesterol transport in conjunction with
APOA-I (Mahley and Rall, 2000; Mahley et al., 2009). APOE and
APOA-I can also induce interleukin-6 (IL-6) and CC chemokine
ligand 2 (CCL2) in MPs in the absence of pathogen-derived li-
gands (Smoak et al., 2010; Levy et al., 2015).
We recently showed that subretinal MPs that accumulate in
AMD strongly express APOE (Levy et al., 2015). The subretinal
MPs ofCx3cr1GFP/GFPmice that develop subretinal inflammation
and cardinal features of AMD (Combadie`re et al., 2007) express
similar high levels of APOE (Levy et al., 2015), but also IL-6 (Levy
et al., 2015) and CCL2 (Sennlaub et al., 2013). We showed that
APOE-induced IL-6 release from MPs represses RPE immune
suppression, prolongs subretinalMP survival, and promotes sub-
retinal inflammation (Levy et al., 2015). Furthermore, we dem-
onstrated that increased levels of CCL2 in Cx3cr1GFP/GFP mice
recruit pathogenic inflammatory CCR2monocytes to the sub-
retinal space (Sennlaub et al., 2013). In consequence, subretinal
pathogenic MPs accumulate in Cx3cr1GFP/GFP mice due to in-
creased MP recruitment and decreased MP elimination. ApoE
deletion inCx3cr1GFP/GFPmice prevented age- and stress-induced
subretinal MP accumulation and reduced associated CNV (Levy
et al., 2015).
We here investigated the influence of the APOE alleles and
isoforms on subretinal inflammation and associated photorecep-
tor degeneration and choroidal neovascularization, major hall-
marks of AMD.
Materials andMethods
Animals.Targeted replacementmice that express humanAPOE isoforms
(TRE2, TRE3, and TRE4 ) were engineered as previously described (Sul-
livan et al., 1997) and provided as a generous gift by Dr. Patrick Sullivan,
backcrossed with C57BL/6 mice to eliminate the Crb1 rd8 contamination
in the three strains and crossed to Cx3cr1GFP/GFPmice (Charles River).
Mice were housed in the animal facility under specific pathogen-free
condition, in a 12/12 h light/dark (100–500 lux) cycle with water and
normal diet food available ad libitum. All experimental protocols and
procedures were approved by the local animal care ethics committee
“Comite´ d’e´thique en expe´rimentation animale Charles Darwin” (Ce5/
2010/013; Ce5/2011/033; Ce5/2010/044).We usedmalemice for choroi-
dal neovascularization experiments, whereas experiments on aged and
light challengedmice were performed onmice of either sex, as we did not
observe differences between the sexes in these conditions.
Light challenge and laser injury model. Two-month-old mice of either
sex were adapted to darkness for 6 h, pupils dilated and exposed to
constant green LED light (starting at 2 A.M., 4500 lux, JP Vezon equipe-
ments) for 4 d as previously described (Sennlaub et al., 2013). Laser
coagulations were performed on male mice with a 532 nm ophthalmo-
logical laser mounted on an operating microscope (Vitra Laser, 532 nm,
450 mW, 50 ms, 250 m) as previously described (Levy et al., 2015).
Intravitreal injections of 2 l of PBS, isotype control rat IgG1, and rat
anti-mouse CD14 (BD Biosciences) were performed using glass capillar-
ies (Eppendorf) and a microinjector. The 2 l solution of the antibodies
was injected at 50g/ml, corresponding to an intraocular concentration
of 5g/ml assuming their dilution by1/10th in the intraocular volume.
Immunohistochemistry, CNV, and MP quantification and histology.
RPE and retinal flatmounts were stained and quantified as previously
described (Sennlaub et al., 2013) using polyclonal rabbit anti-IBA-1
(Wako) and rat anti-mouse CD102 (clone 3C4, BD Biosciences) ap-
propriate secondary antibodies and counterstained with Hoechst if
indicated. Preparations were observed with fluorescence microscope
(DM5500, Leica). Histology of mice eyes and photoreceptor quanti-
fication were performed as previously described (Sennlaub et al.,
2013).
Cell preparations and cell culture. In accordancewith theDeclaration of
Helsinki, volunteers provided written and informed consent for the hu-
man monocyte expression studies, which were approved by the Centre
national d’ophthalmologie des Quinze-Vingt hospital (Paris) ethics
committees (no. 913572). Peripheral blood mononuclear cells were iso-
lated from heparinized venous blood from healthy volunteer individuals
by 1-step centrifugation on a Ficoll Paque layer (GE Healthcare) and
sorted with EasySep Human Monocyte Enrichment Cocktail without
CD16 Depletion Kit (Stem Cell Technology). Mouse peritoneal macro-
phages, bone marrow-derived monocytes, and photoreceptor outer seg-
ment (POS) isolation (all in serum-free X-Vivo 15 medium) were
performed as previously described (Sennlaub et al., 2013). In specific
experiments, cells were stimulated with the different recombinant hu-
man APOE isoforms (5 g/ml, Leinco Technologies), recombinant hu-
man APOE3 90 min heat-denatured (5 g/ml, Leinco Technologies),
APOE3 (5 g/ml) with LPS inhibitor polymyxin B (25 g/ml, Calbio-
chem), rat anti-IgG isotype control (25 g/ml, R&D Systems), rat anti-
mouse CD14 (25 g/ml, R&D Systems), mouse anti-IgG isotype control
(25 g/ml), mouse anti-human TLR2 (25 g/ml, Invivogen), human
IgA2 isotype control (25 g/ml, Invivogen), human anti-human TLR4
(25g/ml, Invivogen), and POS prepared as previously described (Senn-
laub et al., 2013).
Reverse transcription and real-time PCR and ELISA. IL-6, CCL2, and
IL-1 RT-PCRs using Sybr Green (Invitrogen) and ELISAs using mouse
or human IL-6 DuoSet (R&D Systems), mouse or human CCL2 Duoset
(R&D Systems), and humanAPOE Pro kit (Mabtech) were performed as
previously described (Sennlaub et al., 2013; Hu et al., 2015; Levy et al.,
2015).
Statistical analysis. GraphPad Prism 5 (GraphPad Software) was used
for data analysis and graphic representation. All values are reported as
mean SEM. Statistical analysis was performed by one-way or two-way
ANOVA followed byDunnett’s post test orMann–Whitney test for com-
parison among means depending on the experimental design. The p
values are indicated in the figure legends.
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Results
The APOE2 allele leads to age- and stress-related subretinal
MP accumulation, retinal degeneration, and exacerbated
choroidal neovascularization
The subretinal space, located between the RPE and the POS,
does not contain significant numbers of MPs under normal
conditions (Penfold et al., 2001; Gupta et al., 2003; Com-
badie`re et al., 2007; Levy et al., 2015). This is likely the result of
physiologically low levels of chemoattractants along with
strong immunosuppressive RPE signals that quickly eliminate
infiltrating MPs (Sennlaub et al., 2013; Levy et al., 2015). We
have previously shown that the lack of the tonic inhibitory
CX3CL1/CX3CR1 signal, observed in Cx3cr1-deficient mice,
is sufficient to induce pathogenic chronic subretinal MP accu-
mulation as a consequence of increased recruitment and de-
creased elimination (Combadie`re et al., 2007; Sennlaub et al.,
2013; Levy et al., 2015). We showed that this accumulation is
dependent on the overexpression of APOE in Cx3cr1-deficient
MPs (Levy et al., 2015). To evaluate a potential role of the human
APOE isoforms in subretinal inflammation, we used targeted re-
placement mice expressing human isoforms (TRE2, TRE3, and
TRE4) (Sullivan et al., 1997). We first backcrossed the strains
with C57BL/6J mice to eliminate the Crb1rd8 contamination in
the three strains, which can lead to AMD-like features (Mattapal-
lil et al., 2012). The mice were raised under 12 h light/12 h dark
cycles at 100–500 lux at the cage level, with no additional cover in
the cage, the conditions that induce MP accumulation in
Cx3cr1-deficient mice with age (Combadie`re et al., 2007). Quan-
tification of subretinal IBA-1MPs on retinal and RPE/choroi-
dal flatmounts of 2- and 12-month-old TRE2, TRE3, and TRE4
mice revealed that TRE2mice develop age-dependent subretinal
MP accumulation compared with TRE3 and TRE4 mice (Fig.
1A). Similarly, TRE2 mice accumulated significantly more sub-
retinal MPs after a 4 d light challenge, and the MPs continued to
accumulate after return for 10 additional days in normal light
conditions (Fig. 1B; the intensity of our light challenge model
Figure 1. The APOE2 allele leads to age- and stress-related subretinal MP accumulation, retinal degeneration, and exacerbated choroidal neovascularization. A, Representative 12-month-old
IBA-1-stained RPE flatmounts of TRE3 and TRE2mice andquantification of subretinal IBA-1MPs in 2- and 12-month-oldmice of the indicated strains (n 9–20/group). *p 0.0001, 12months
versus TRE3 control (ANOVA/Dunnett’s multiple-comparison test). B, Quantification of subretinal IBA-1 MPs after a 4 d light challenge followed by 10 d of normal light conditions (d14) of
2-month-old mice of the indicated strains (n 14–16/group). *p 0.0001, versus TRE3 control at 14 d (ANOVA/Dunnett’s multiple-comparison test). C, Micrographs taken 1000m from the
optic nerve of 12-month-old TRE3 and TRE2mice. ONL, Outer nuclear layer. C, Photoreceptor nuclei rows at increasing distances (3000m: inferior pole; 3000m: superior pole) from the optic
nerve (0m) in 12-month-oldmice. C, Quantification of the area under the curve of photoreceptor nuclei row counts of 2- and 12-month-old transgenic mouse strains (n 4–7). *p 0.0102,
versus TRE3 control at 12 months (ANOVA/Dunnett’s multiple-comparison test). Mice were taken from several (3) independent cages for the quantifications. D, CD102 (red) and IBA-1 (green)
immunohistochemistry and quantification of subretinal IBA-1MPs on the RPE counted at a distance of 0–500m to CD102 CNV 7 d after the laser injury of 2-month-oldmice of the indicated
strains (n8–10/group). *p0.0001 (one-wayANOVA/Dunnett’smultiple-comparison test).E, CD102 immunohistochemistry andquantificationof CD102areaonRPE/choroidal flatmount from
2-month-old transgenic strains, 7 d after laser injury (n 8–10/group). *p 0.0001 (one-way ANOVA/Dunnett’s multiple-comparison test). TRE2–4, Targeted replacement mice expressing
human APOE isoforms Scale bars: A, C–E, 50m .
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used herein was calibrated to induce subretinal inflammation in
inflammation-prone Cx3cr1GFP/GFP mice but not in WT mice)
(Sennlaub et al., 2013).
We also observed a thinning of the outer nuclear layer that
contains the photoreceptor nuclei on histological retinal sections
from 12-month-old TRE2mice compared with TRE3mice (Fig.
1C; micrographs taken at equal distance from the optic nerve).
Photoreceptor nuclei row counts (Fig. 1C	) and calculation of the
area under the curve (Fig. 1C
) revealed
that the age-related accumulation of sub-
retinal MPs in TRE2 mice is associated
with significant photoreceptor cell loss
compared with TRE3 and TRE4mice.
In addition, in laser-induced CNV,
subretinal IBA-1 MPs (green staining,
counted on the RPE at a distance of 0–500
m to CD102 CNVs, red staining) were
significantly more numerous in TRE2
mice 7 d after a laser impact (Fig. 1D) and
had developed significantly greater CNV
lesions (Fig. 1E) compared with the other
strains.
Together, our data demonstrate that
TRE2 mice, expressing the APOE2 AMD
risk allele, develop age-related subretinal
inflammation and photoreceptor degen-
eration and exaggerated inflammation
and CNV after laser injury similar to late
AMD.
The APOE2 allele increases APOE levels
in the eye and APOE transcription and
innate immunity receptor cluster
(IIRC) activation inMPs
We previously showed that the levels of
soluble APOE are elevated in adult
TRE2 mouse brains and diminished in
TRE4 brains compared with TRE3 mice
in a model of AD (Bales et al., 2009).
Similarly, ELISA of APOE levels of ho-
mogenates of PBS-perfused posterior
segments (retina and RPE/choroid
plexus) of 12-month-old mice revealed
significantly higher levels of APOE in
TRE2 mice compared with TRE3 and
TRE4 mice (Fig. 2A). Furthermore,
immunohistochemical localization of
APOE on retinal flatmounts of TRE2
mice (Fig. 2B, red staining) revealed
strong APOE expression in subretinal
IBA-1 MPs (Fig. 2B, green staining).
The polymorphism rs7412 that de-
fines the APOE2 isoform also leads to
the loss of a CpG site in the APOE2 allele
that has been shown to moderately, but
significantly, increase APOE transcrip-
tion in brain astrocytes, but not in hepa-
tocytes (Yu et al., 2013). Our data
confirm that APOE transcription in
hepatocytes does not differ between ge-
notypes (Yu et al., 2013) (Fig. 2C, RT-
PCR) and that APOE concentrations in
the blood were significantly increased in
TRE2mice (Fig. 2D, blood plasma ELISA), shown to be due to
its decreased clearance rate (Mahley and Rall, 2000). However,
bone marrow-derived monocytes (cultured with POS for 3 d
to mimic subretinal macrophage differentiation) (Fig. 2E, RT-
PCR) and peritoneal macrophages (Fig. 2F, RT-PCR) from
TRE2 mice transcribed significantly higher levels of ApoE
mRNA compared with MPs of the other mouse strains. Ac-
Figure 2. The APOE2 allele increases APOE levels in the eye and APOE transcription and IIRC activation inMPs. A, APOE ELISA of
homogenates of PBS-perfused posterior segments of 12-month-old TRE2, TRE3, and TRE4mice (n 5 or 6/group). *p 0.0027,
versus TRE3 control (one-way ANOVA/Dunnett’s multiple-comparison test). ‡p 0.0027 (one-way ANOVA/Dunnett’s multiple-
comparison test). B, Immunohistochemistry of APOE (red, top) and IBA-1 (green, bottom) of the subretinal side of a retinal
flatmount froma12-month-old TRE2mouse (representativeof three independent experiments; experiments omitting theprimary
antibody immunostaining served as negative controls). C, Quantitative RT-PCR of ApoEmRNA normalized with S26mRNA of liver
extracts from transgenic replacement mice expressing human APOE isoforms (TRE2, TRE3, and TRE4 mice, n  3). D, ELISA
quantification of APOE plasma concentrations in transgenic replacement mice expressing human APOE isoforms (TRE2, TRE3, and
TRE4 mice, n 3). *p 0.0001, versus TRE3 control (ANOVA/ Dunnett’s multiple-comparison test). E, Quantitative RT-PCR of
ApoEmRNAnormalizedwith S26mRNAof bonemarrow-derivedmonocytes from transgenic replacementmice expressing human
APOE isoforms (TRE2, TRE3, and TRE4 mice) cultured for 3 d with or without porcine photoreceptor outer segments to simulate
subretinal monocyte to macrophage differentiation (n 6/group). *p 0.0033, MoPOS versus TRE3 control (ANOVA/ Dun-
nett’s multiple-comparison test). F, Quantitative RT-PCR of ApoE mRNA normalized with S26 mRNA of peritoneal Ms from TRE
mice cultured for 24 h (n 6). *p 0.0001, versus TRE3 control (ANOVA/Dunnett’s multiple-comparison test).G, APOE-ELISA of
supernatants of peritoneal Ms from TRE mice cultured for 24 h (n 6). *p 0.0001, versus TRE3 control (ANOVA/Dunnett’s
multiple-comparison test). H, Human IL-6 ELISA of supernatants from human monocytes incubated for 24 h in control medium,
APOE3 (5 g/ml), heat-denaturated APOE3 (dAPOE3, 5 g/ml), APOE3 (5 g/ml), and polymyxin B (25 g/ml), APOE3 (5
g/ml), and rat IgG1 isotype, or human IgA2 isotype control, or mouse IgG1 isotype control, or rat anti-CD14 IgG1 antibody, or
human anti-TLR4 IgGA2 antibody, or mouse anti-TLR2 IgG1 antibody (all antibodies at 25 g/ml) (n 4–6/group). *p
0.0001, APOE3 versus CTL (one-way ANOVA/Bonferronimultiple-comparison test). #p 0.0001, dAPOE3 versus APOE3 (one-way
ANOVA/Bonferroni multiple-comparison test). #p 0.0001, APOE3 IgG versus APOE3 aCD14 Ab (one-way ANOVA/Bonferroni
multiple-comparison test). #p 0.0001, APOE3 IgG versus APOE3 aTLR4 Ab (one-way ANOVA/Bonferroni multiple-comparison
test). #p 0.0001, APOE3 IgA versus APOE3 aTLR2 Ab (one-way ANOVA/Bonferroni multiple-comparison test). I, Quantitative
RT-PCR of Il-6, Ccl-2, and II1mRNAnormalizedwith S26mRNA (n 6) of peritonealMs from TREmice cultured for 24 h. *p
0.0069, versus TRE3 control IL-6 (ANOVA/Dunnett’s multiple-comparison test). *p 0.0001, versus TRE3 control CCL2 (ANOVA/
Dunnett’s multiple-comparison test). *p  0.0097, versus TRE3 control IL-1 (ANOVA/Dunnett’s multiple-comparison test).
TRE2–4, Targeted replacement mice expressing human APOE isoforms. Scale bar: B, 50m.
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cordingly, the APOE secretion of TRE2
mice macrophages was robustly in-
creased (Fig. 2G, ELISA of supernatant)
compared with the other groups.
APOE and APOA-I have been shown
to activate the TLR2-TLR4 CD14-
dependent IIRC in mouse peritoneal
macrophages in the absence of pathogen-
derived ligands and to induce inflamma-
tory cytokines, such as IL-6 (Smoak et al.,
2010; Levy et al., 2015), but also CCL2
(shown for APOA-I) (Smoak et al., 2010).
We here show that human blood-derived
CD14 monocytes significantly secrete
IL-6 after 24 h of recombinant lipid-free
APOE3 stimulation (Fig. 2H) similar to
mouse macrophages. Ninety minute heat
denaturation completely abolished the in-
duction, whereas the LPS inhibitor poly-
myxin B did not, confirming that LPS contamination of APOE3
is not accountable for the effect, as shown for APOA-I using
multiple approaches (Smoak et al., 2010). This inductionwas due
to the activation of the TLR2-TLR4 CD14-dependent IIRC, as
neutralizing antibodies to CD14, TLR2, and TLR4 inhibited this
effect, compared with control antibodies (Fig. 2H). Accordingly,
peritoneal macrophages from TRE2 mice that express increased
amounts of APOE (Fig. 2C,D) also transcribed significantlymore
IL-6, CCL2, and IL-1 compared with macrophages of the other
isoforms (Fig. 2I).
Together, our results show that the APOE2 allele increases
APOE levels in the tissue and APOE expression in MPs. We con-
firm that APOE activates the IIRC and show that the excessive
APOE expression in macrophages from TRE2mice is associated
with increased production of inflammatory cytokines in vitro.
IIRC inhibition reduces subretinal MP accumulation and
choroidal neovascularization in TRE2mice in vivo
To evaluate whether increased IIRC activation is implicated in
subretinal MP accumulation observed in TRE2 mice in vivo, we
inhibited the IIRC by an intravitreal injection of a CD14-
neutralizing antibody in the laser-induced CNV model (Figure
3). The antibody, which blocks APOE-dependent cytokine in-
duction (Levy et al., 2015), inhibited subretinal MP accumula-
tion around the laser injury, quantified on IBA1-stained RPE/
choroidal flatmounts (Fig. 3A) and CD102 CNV formation
(Fig. 3B) at day 7 after laser injury of TRE2mice compared with
control IgG.
These results confirm that the CD14-dependent inflamma-
tory cytokine induction participates in subretinal MP accumula-
tion in TRE2mice in vivo, similar to Cx3cr1GFP/GFP mice (Levy et
al., 2015).
The APOE4 allele protects APOE-overexpressing
Cx3cr1GFP/GFPmice from subretinal MP accumulation, retinal
degeneration, and exacerbated choroidal neovascularization
Cx3cr1-deficientmice lack the tonic inhibitory signal of neuronal
CX3CL1 and develop subretinal MP accumulation and concom-
itant photoreceptor degeneration with age when raised in cyclic
light at 100–500 lux (Combadie`re et al., 2007; Chinnery et al.,
2012; Sennlaub et al., 2013; Hu et al., 2015; Levy et al., 2015). The
accumulation can be prevented by raising the animals in darkness
(Combadie`re et al., 2007) or in dim light conditions (Luhmann et
al., 2013) and be accelerated by a light challenge (Sennlaub et al.,
2013; Hu et al., 2015; Levy et al., 2015) (for more details, see
Sennlaub et al., 2013, mini review in supplemental data). Al-
though these features do not mimic all the aspects of AMD
(Drusen formation and RPE atrophy), they do model subretinal
inflammation and associated photoreceptor degeneration, two
hallmarks of AMD (Gupta et al., 2003). Cx3cr1 deletion also in-
creases subretinal MP accumulation in diabetes (Kezic et al.,
2013), in a paraquat-induced retinopathy model (Chen et al.,
2013), and in a retinitis pigmentosamodel (Peng et al., 2014).We
previously demonstrated that pathogenic MPs accumulate in
Cx3cr1-deficient mice due to the overexpression of APOE, IL-6,
and CCL2 (Sennlaub et al., 2013; Levy et al., 2015). To evaluate a
possible influence of the APOE4 isoform in a model of patholog-
ical subretinal inflammation, we crossed TRE3 and TRE4mice to
Cx3cr1GFP/GFP mice (Levy et al., 2015).
Quantification of subretinal IBA-1 MPs on retinal and
RPE/choroidal flatmounts of 2- and 12-month-old
Cx3cr1GFP/GFPTRE3 mice and Cx3cr1GFP/GFPTRE4 mice revealed
that the age-dependent subretinal MP accumulation observed in
Cx3cr1GFP/GFPTRE3 mice was prevented in Cx3cr1GFP/GFPTRE4
mice (Fig. 4A). A 4 d light challenge led to similar initial subreti-
nal MP accumulation, but the increase of MPs after return
to normal light conditions was significantly blunted in
Cx3cr1GFP/GFPTRE4 mice compared with Cx3cr1GFP/GFPTRE3
mice (Fig. 4B).
Furthermore,micrographs of histological sections of 12-month-
oldmice revealeda thickerouternuclear layer inCx3cr1GFP/GFPTRE4
micecomparedwith the thinnedCx3cr1GFP/GFPTRE3mice (Fig. 4C).
Photoreceptor nuclei row counts (Fig. 4C	) and calculation of the
area under the curve (Fig. 4C
) show that the inhibition of the age-
related accumulation of subretinalMPs inCx3cr1GFP/GFPTRE4mice
compared with Cx3cr1GFP/GFPTRE3mice significantly inhibited the
associated photoreceptor cell loss. The age-related subretinal MP
accumulation and photoreceptor degeneration observed in
Cx3cr1GFP/GFPTRE3mice are significantly increased compared with
TRE3 mice presented in Figure 1, similar to Cx3cr1GFP/GFP mice
expressing mouse APOE (Sennlaub et al., 2013) (MP/mm2 of
12-month-old mice: TRE3 mice: 7.315  1.72 SEM;
Cx3cr1GFP/GFPTRE3 mice: 16.6  2.22 SEM; area under the curve:
TRE3mice: 148.3 1.52 SEM; Cx3cr1GFP/GFPTRE3mice: 137.3
2.12 SEM).
Figure3. IIRC inhibition reduces subretinalMP accumulation and choroidal neovascularization in TRE2mice in vivo.A,B, Seven
day laser-injured IBA-1 (green) and CD102 (red) stained RPE flatmounts of control IgG and anti-CD14-treated TRE2 mice. Quanti-
fication of subretinal IBA-1MPs/impact localized on the lesion surrounding RPE (A) and quantification of CD102 CNV area (B)
of TRE2mice treated with control IgG or CD14-blocking antibodies (intraocular antibody concentration 5g/ml; n 12/group).
A, *p 0.0012 (Mann–Whitney t test).B, *p 0.0009 (Mann–Whitney t test). TRE2–4, Targeted replacementmice expressing
human APOE isoforms; Scale bars: A and B, 50m.
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Moreover, laser-induced subretinal IBA-1MPs in 2-month-
old mice (green staining) adjacent to CD102 CNVs (red stain-
ing) was again significantly inhibited inCx3cr1GFP/GFPTRE4mice
compared with Cx3cr1GFP/GFPTRE3 mice (Fig. 4D) and had de-
veloped significantly greater CNV lesions at 14 d after laser injury
(Fig. 4E) compared with the other strains.
In summary, our data demonstrate that the APOE4 allele,
which is protective for AMD, inhibits subretinal inflammation
and concomitant degeneration and CNV in Cx3cr1 deficiency
compared with APOE3.
The APOE4 allele decreases ocular APOE levels in
Cx3cr1GFP/ GFPmice and activates the IIRC inefficiently
To investigate whether the APOE3 and APOE4 allele influences
the APOE level in the eyes of Cx3cr1GFP/GFPTRE mice, we ana-
lyzed APOE levels of homogenates of PBS-perfused posterior
segments (retina and RPE/choroid plexus) of 12-month-old
mice. APOE levels were significantly lower in homogenates
of 12-month-old Cx3cr1GFP/GFPTRE4 mice compared with
Cx3cr1GFP/GFPTRE3mice (Fig. 5A), similar to APOE levels in the
eyes of TREmice (see above) and brains of PDAPPmice express-
ing human APOE isoforms (Bales et al., 2009).
APOA-I and APOE likely activate the IIRC by modifying the
cholesterol content of the lipid rafts in which they are located
(Smoak et al., 2010). As the APOE4 isoform has an impaired
capacity to promote cholesterol efflux and transport (Heeren et
al., 2004; Mahley et al., 2009), we next tested its ability to activate
the IIRC of blood-derived humanmonocytes in culture. Interest-
ingly, stimulation of monocytes for 24 h by recombinant APOE4
induced significantly less IL-6 and CCL2 secretion compared
with the induction of the cytokines by equimolar concentrations
of APOE3 (Fig. 5B).
APOE transcription (Fig. 5C, RT-PCR) and APOE secretion
(Fig. 5D, ELISA of supernatant) in peritoneal macrophages from
Cx3cr1GFP/GFPTRE3 mice and Cx3cr1GFP/GFPTRE4 mice were
comparable, similar to previous reports from astrocytes: the
Figure 4. The APOE4 allele protects APOE-overexpressing Cx3cr1 GFP/GFP mice from subretinal MP accumulation, retinal degeneration, and exacerbated choroidal neovascularization. A, Repre-
sentative 12-month-old IBA-1-stained RPE flatmounts of Cx3cr1GFP/GFPTRE3 mice and Cx3cr1GFP/GFPTRE4 mice and quantification of subretinal IBA-1 MPs in 2- and 12-month-old mice of the
indicated strains (n 8–13/group). *p 0.0034 (Mann–Whitney t test at 12 months). B, Quantification of subretinal IBA-1MPs after a 4 d light challenge followed by 10 d of normal light
conditions (d14) of 2-month-old mice of the indicated strains (n 18/group). *p 0.0036 (Mann–Whitney t test at d14). C, Micrographs, taken 1000m from the optic nerve of 12-month-old
Cx3cr1GFP/GFPTRE3 mice and Cx3cr1GFP/GFPTRE4 mice. ONL, Outer nuclear layer. C, Photoreceptor nuclei rows at increasing distances (3000m: inferior pole; 3000m: superior pole) from the
optic nerve (0m) in 12-month-old mice. C, Quantification of the area under the curve of photoreceptor nuclei row counts of 12-month-old transgenic mouse strains (n 5–9). *p 0.0032
(Mann–Whitney t test). Mice were taken from several (3) independent cages for the quantifications. D, CD102 (red) and IBA-1 (green) immunohistochemistry and quantification of subretinal
IBA-1MPs on the RPE counted at a distance of 0–500m to CD102 CNV 14 d after the laser injury of 2-month-old mice of the indicated strains (n 7/group). *p 0.0182 (Mann–Whitney
t test). E, CD102 immunohistochemistry and quantification of CD102 area on RPE/choroidal flatmount from 2-month-old transgenic strains, 14 d after laser injury (n 7/group). *p 0.0034
(Mann–Whitney t test). Scale bars: A, C–E, 50m.
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APOE4 allele did not diminish APOE pro-
duction (Yu et al., 2013). However, in ac-
cordance with a decreased ability to
activate the IIRC, peritonealmacrophages
from Cx3cr1GFP/GFPTRE4 mice tran-
scribed significantly less CCL2 compared
with macrophages from Cx3cr1GFP/GFP
TRE3 mice, whereas the IL-6 transcrip-
tionwas variable, but not significantly dif-
ferent (Fig. 5E).
Together, our results show that the
APOE4 allele leads to decreased APOE tis-
sue levels and to a reduced capacity to ac-
tivate the IIRC and induce CCL2 in MPs.
Discussion
We have previously shown that the lack of
the tonic inhibitory CX3CL1/CX3CR1
signal, observed in Cx3cr1-deficient mice,
is sufficient to induce pathogenic chronic
subretinal MP accumulation due to in-
creased CCL2-dependent monocyte re-
cruitment and IL-6-dependent decrease
of subretinal MP elimination (Com-
badie`re et al., 2007; Sennlaub et al., 2013;
Hu et al., 2015; Levy et al., 2015). We
showed that this accumulation is depen-
dent on the overexpression of APOE in
Cx3cr1-deficient MPs (Levy et al., 2015).
As the APOE isoforms are associated with
significant differences in APOE levels in
humans (Mahley and Rall, 2000) and in
humanized transgenic mice expressing
APOE isoforms (Bales et al., 2009; Yu et
al., 2013), we here evaluated the conse-
quences of the three isoforms on chori-
oretinal homeostasis.
Our study shows that TRE2 mice, carrying the AMD risk al-
lele, develop age-, light-, and laser-induced subretinal MP accu-
mulation associated with photoreceptor degeneration and
excessive CNV. TRE2 mice displayed increased tissue levels of
APOEmeasured inwhole retinal/choroidal protein extracts com-
pared with TRE3 and TRE4 mice. This increase is likely due to
reduced LDLR-dependent APOE2 uptake (Fryer et al., 2005) of
APOE that is produced in the RPE, the inner retina
and by subretinal MPs (Anderson et al., 2001; Levy et al., 2015).
Similar to CX3CR1GFP/GFP mice and AMD patients (Levy et al.,
2015), subretinal MPs in TRE2mice stained strongly positive for
APOE. In vitro, we show that the APOE2 allele is associated with
increased APOE transcription and secretion in macrophages
from TRE2 mice, as previously shown for astrocytes (Yu et al.,
2013). The APOE levels in and around subretinal MPs are there-
fore likely elevated because of increased APOE transcription and
decreased LDLR-dependent clearance in the tissue. It is not yet
clear to what extent APOE from nonmyeloid cells participates in
the subretinal inflammation and whether extracellular or intra-
cellular APOE within the MPs is the determining factor.
APOE is capable of activating the CD14/TLR2/TLR4-
dependent IIRC and inducing IL-6, as previously shown for
mouse macrophages (Smoak et al., 2010; Levy et al., 2015). We
here confirm that APOE can induce inflammatory cytokines in a
similar manner in human monocytes. Moreover, macrophages
from TRE2mice that express significantly higher levels of APOE
also transcribed higher levels of inflammatory cytokines, such as
IL-6, CCL2, and IL-1, in accordancewith anAPOE activation of
the IIRC and similar to APOE-overexpressing Cx3cr1-deficient
macrophages (Sennlaub et al., 2013; Hu et al., 2015; Levy et al.,
2015). We previously showed that CCL2 (Sennlaub et al., 2013)
and IL-6 (Levy et al., 2015) promote subretinalMP accumulation
by increasing monocyte recruitment and decreasing MP clear-
ance, respectively. Indeed, inhibition of the IIRC by a CD14-
blocking antibody in laser-injured TRE2 mice decreased
subretinal MP accumulation and neovascularization. These re-
sults demonstrate that IIRC activation is significantly involved in
the subretinal MP accumulation in TRE2mice in vivo. Together,
Cx3cr1GFP/GFP mice and TRE2 mice both overexpress APOE in
mononuclear phagocytes, although for different reasons. In both
mouse strains, the increased APOE is associated with IIRC acti-
vation, CCL2 and IL-6 induction, and pathogenic subretinal in-
flammation. Although these features do notmimic all the aspects
of AMD (Drusen formation and RPE atrophy), they do model
subretinal inflammation and associated photoreceptor degener-
ation, two hallmarks of AMD (Gupta et al., 2003). We previously
demonstrated the importance of APOE in this process, as APOE
deletion protected Cx3cr1GFP/GFP mice against the inflammation
(Levy et al., 2015). Interestingly, increased levels of CCL2 and
IL-6 are also observed in late AMD (Seddon et al., 2005; Jonas et
al., 2010; Sennlaub et al., 2013; Chalam et al., 2014), where
chronic MP accumulation is observed (Penfold et al., 2001;
Gupta et al., 2003; Combadie`re et al., 2007; Sennlaub et al., 2013;
Figure 5. TheAPOE4 allele decreases ocular APOE levels in Cx3cr1 GFP/GFPmice and activates the IIRC inefficiently.A, APOE ELISA
of homogenates of PBS-perfused posterior segments of 12-month-old Cx3cr1GFP/GFPTRE3 mice and Cx3cr1GFP/GFPTRE4 mice (n
8–11/group). *p 0.0276 (Mann–Whitney t test). B, Human IL-6 and CCL2 ELISA of supernatants from human monocytes
incubated for 24 h in control medium, APOE3 (5 g/ml), or APOE4 (5 g/ml) (n 6). p 0.0001, IL-6 and CCL2 (one-way
ANOVA/Bonferroni multiple-comparison tests). *p  0.05, different from control (one-way ANOVA/Bonferroni multiple-
comparison tests). ‡p 0.05, different from APOE3 (one-way ANOVA/Bonferroni multiple-comparison tests). C, D, Quantitative
RT-PCR of ApoEmRNA normalized with S26mRNA (C, n 4) and APOE-ELISA of supernatants (D, n 4) of peritoneal Ms from
TREmice cultured for 24h.E, Quantitative RT-PCRof Il-6 andCcl2mRNAnormalizedwith S26mRNA (n5–10) of peritonealMs
from TRE mice cultured for 24 h. ‡p 0.0035, compared with CCL2 from Cx3cr1G/GTRE3 Ms (Mann–Whitney t test).
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Levy et al., 2015). The observation that inhibition of subretinal
MP accumulation in a variety of animal models represses CNV
(Sakurai et al., 2003; Tsutsumi et al., 2003; Liu et al., 2013) and
degeneration (Guo et al., 2012; Rutar et al., 2012; Suzuki et al.,
2012; Kohno et al., 2013) strongly suggests that chronic subreti-
nal inflammation partakes in AMD pathogenesis.
The chronic nonresolving inflammation in AMD is associated
with an increase in APOE (Klaver et al., 1998; Anderson et al.,
2001; Levy et al., 2015) similar to other inflammatory conditions
(Rosenfeld et al., 1993). To evaluate whether a potential influence
of the protective APOE4 allele would become apparent in a situ-
ation of increased inflammation and APOE abundance,
we crossed TRE3 and TRE4 mice to the APOE-overexpressing
Cx3cr1GFP/GFP mice. In the inflammatory context of
Cx3cr1GFP/GFP mice, the APOE4 allele led to diminished APOE
levels and the APOE4 allele protected Cx3cr1GFP/GFPmice against
harmful subretinal MP accumulation observed in APOE3-
carrying Cx3cr1GFP/GFP mice. APOE4 is characterized, among
others, by its decreased capacity to transport cholesterol com-
paredwith APOE3 (Heeren et al., 2004) andmight thereby be less
capable ofmodifying the cholesterol content of the lipid rafts and
activating the IIRC (Smoak et al., 2010). Indeed, our results show
that recombinant APOE4 induced less IL-6 and CCL2 compared
with equimolar APOE3 concentrations in human monocytes in
vitro. Similarly, macrophages from Cx3cr1GFP/GFPTRE4 mice
transcribed less CCL2 compared with macrophages from
Cx3cr1GFP/GFPTRE3 mice, although their APOE expression was
comparable. It is not clear why Cx3cr1GFP/GFPTRE4macrophages
did not differ from Cx3cr1GFP/GFPTRE3macrophages in terms of
IL-6 transcription levels. Other unknown regulatory elements
likely influence the transcription of the individual cytokines in
macrophages, and the interplay of Cx3cr1 deficiency and the
human APOE3 and APOE4 isoform in the mouse macrophages
might affect these pathways. We previously showed that CCL2
inhibition in Cx3cr1GFP/GFP mice significantly inhibited age-,
laser-, and light-induced subretinal MP accumulation (Sennlaub
et al., 2013) and diminished production of CCL2, as a result of
reducedAPOE concentrations andAPOE4’s impaired capacity to
induce cytokines might explain the reduced inflammation and
inhibition of degeneration and CNV observed in Cx3cr1GFP/GFP
TRE4mice.
To our knowledge, this is the first study to describe a compre-
hensive pathomechanism of the involvement of APOE isoforms
in AMD that is in accordance with the clinical observation of the
APOE2 allele being an AMD risk factor and the APOE4 allele an
AMD-protective genetic factor. One previous study demon-
strated that TRE4mice on high-fat diet develop lipid accumula-
tions in the Bruch’smembrane, proposed as similar to early AMD
(Malek et al., 2005), which are also observed in ApoE/ mice
(Ong et al., 2001). Although these observations might apply to
early AMD, they are unlikely to play a role in late AMD in which
increased APOE immunoreactivity is observed (Klaver et al.,
1998; Anderson et al., 2001; Levy et al., 2015) and in which the
APOE4 allele plays a protective role (McKay et al., 2011). The
involvement of increased reverse cholesterol transport in AMD
might also be supported by the observation that APOA-I levels
are elevated in the vitreous of AMD patients (Koss et al., 2014).
Furthermore, a polymorphism of the ATP-binding cassette
transporter 1 (associated with low high-density lipoprotein and
therefore possibly impaired reverse cholesterol transport) has re-
cently been shown to be protective against advanced AMD (Chen
et al., 2010).
Our study also sheds an interesting light on the puzzling dif-
ferences of the APOE isoform association with AMD (McKay et
al., 2011) and AD (Mahley and Rall, 2000), twomajor age-related
neurodegenerative diseases. In AD, theAPOE4 allele is associated
with greater -amyloid burden, possibly due to decreased APOE
tissue concentrations and reduced efficacy in clearance of
-amyloid clearance via multiple pathways (Bales et al., 2009;
Mahley et al., 2009). Cx3cr1GFP/GFP mice that express increased
amounts of APOE in all MPs, including MCs (Levy et al., 2015),
are protected against -amyloid deposition in ADmousemodels
(Lee et al., 2010). In AMD, we show that excessive APOE expres-
sion associated with the AMD-risk APOE2 allele leads to the in-
duction of inflammatory cytokines that promote pathogenic
subretinal inflammation (Figs. 1, 2, 3) (Levy et al., 2015), similar
to Cx3cr1-deficient mice (Combadie`re et al., 2007; Sennlaub et
al., 2013; Peng et al., 2014; Levy et al., 2015). On the other hand,
we show that the APOE4 allele is protective in the context of
APOE overexpression of Cx3cr1GFP/GFP mice (Levy et al., 2015),
due to decreasedAPOE tissue concentrations (Riddell et al., 2008;
Bales et al., 2009; Sullivan et al., 2011) and its reduced capacity to
induce inflammatory cytokines (Figs. 4, 5).
Together, our study shows that the APOE2 allele leads to in-
creased APOE expression, IIRC activation, and subretinal in-
flammation, whereas the APOE4 allele diminishes IIRC
activation and inflammation. Our study provides the rationale
for the previously unexplained implication of the APOE geno-
type in AMD and opens avenues toward therapies inhibiting
pathogenic chronic inflammation in late AMD.
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